List of Tables
Table 1. Central Nervous System Therapeutic Market Trends
Table 2. Central Nervous System Therapeutic Market Drivers & Opportunity
Table 3. Central Nervous System Therapeutic Market Challenges
Table 4. Central Nervous System Therapeutic Market Restraints
Table 5. Global Central Nervous System Therapeutic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Central Nervous System Therapeutic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Central Nervous System Therapeutic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Central Nervous System Therapeutic Product Type
Table 9. Key Companies Time to Begin Mass Production of Central Nervous System Therapeutic
Table 10. Global Central Nervous System Therapeutic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapeutic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Central Nervous System Therapeutic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Central Nervous System Therapeutic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Central Nervous System Therapeutic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Central Nervous System Therapeutic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Central Nervous System Therapeutic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Central Nervous System Therapeutic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Central Nervous System Therapeutic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Central Nervous System Therapeutic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Central Nervous System Therapeutic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Central Nervous System Therapeutic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Central Nervous System Therapeutic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Central Nervous System Therapeutic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Central Nervous System Therapeutic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Central Nervous System Therapeutic Sales Value by Region (2019-2024) & (%)
Table 27. Global Central Nervous System Therapeutic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Central Nervous System Therapeutic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Central Nervous System Therapeutic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Central Nervous System Therapeutic Sales Value, (2025-2030) & (US$ Million)
Table 31. Biogen Basic Information List
Table 32. Biogen Description and Business Overview
Table 33. Biogen Central Nervous System Therapeutic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Biogen (2019-2024)
Table 35. Biogen Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Central Nervous System Therapeutic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Teva Basic Information List
Table 42. Teva Description and Business Overview
Table 43. Teva Central Nervous System Therapeutic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Teva (2019-2024)
Table 45. Teva Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Central Nervous System Therapeutic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Johnson & Johnson Basic Information List
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Central Nervous System Therapeutic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Johnson & Johnson (2019-2024)
Table 55. Johnson & Johnson Recent Developments
Table 56. EliLilly Basic Information List
Table 57. EliLilly Description and Business Overview
Table 58. EliLilly Central Nervous System Therapeutic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Central Nervous System Therapeutic Business of EliLilly (2019-2024)
Table 60. EliLilly Recent Developments
Table 61. Otsuka Basic Information List
Table 62. Otsuka Description and Business Overview
Table 63. Otsuka Central Nervous System Therapeutic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Otsuka (2019-2024)
Table 65. Otsuka Recent Developments
Table 66. Merck Basic Information List
Table 67. Merck Description and Business Overview
Table 68. Merck Central Nervous System Therapeutic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Merck (2019-2024)
Table 70. Merck Recent Developments
Table 71. AstraZeneca Basic Information List
Table 72. AstraZeneca Description and Business Overview
Table 73. AstraZeneca Central Nervous System Therapeutic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Central Nervous System Therapeutic Business of AstraZeneca (2019-2024)
Table 75. AstraZeneca Recent Developments
Table 76. Novartis Basic Information List
Table 77. Novartis Description and Business Overview
Table 78. Novartis Central Nervous System Therapeutic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Novartis (2019-2024)
Table 80. Novartis Recent Developments
Table 81. Takeda Basic Information List
Table 82. Takeda Description and Business Overview
Table 83. Takeda Central Nervous System Therapeutic Products, Services and Solutions
Table 84. Revenue (US$ Million) in Central Nervous System Therapeutic Business of Takeda (2019-2024)
Table 85. Takeda Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Central Nervous System Therapeutic Downstream Customers
Table 89. Central Nervous System Therapeutic Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Central Nervous System Therapeutic Product Picture
Figure 2. Global Central Nervous System Therapeutic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Central Nervous System Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 4. Central Nervous System Therapeutic Report Years Considered
Figure 5. Global Central Nervous System Therapeutic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Central Nervous System Therapeutic Revenue in 2023
Figure 7. Central Nervous System Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. OTC Picture
Figure 9. Rx Drugs Picture
Figure 10. Global Central Nervous System Therapeutic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Central Nervous System Therapeutic Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Retail Pharmacy
Figure 14. Global Central Nervous System Therapeutic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Central Nervous System Therapeutic Sales Value Market Share by Application, 2023 & 2030
Figure 16. North America Central Nervous System Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 17. North America Central Nervous System Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 18. Europe Central Nervous System Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 19. Europe Central Nervous System Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 20. Asia Pacific Central Nervous System Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 21. Asia Pacific Central Nervous System Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 22. South America Central Nervous System Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 23. South America Central Nervous System Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 24. Middle East & Africa Central Nervous System Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 25. Middle East & Africa Central Nervous System Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 26. Key Countries/Regions Central Nervous System Therapeutic Sales Value (%), (2019-2030)
Figure 27. United States Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 28. United States Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 29. United States Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 30. Europe Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 32. Europe Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 33. China Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 34. China Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 35. China Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 36. Japan Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 37. Japan Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 38. Japan Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 39. South Korea Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 40. South Korea Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 41. South Korea Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 42. Southeast Asia Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 44. Southeast Asia Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 45. India Central Nervous System Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 46. India Central Nervous System Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 47. India Central Nervous System Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 48. Central Nervous System Therapeutic Industrial Chain
Figure 49. Central Nervous System Therapeutic Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
